Topic

Retevmo (selpercatinib)

A collection of 24 issues

How to Get Retevmo (Selpercatinib) Covered by Cigna in Texas: Appeals, Copay Cards & Cost Solutions

Quick Answer: Getting Retevmo (Selpercatinib) Covered by Cigna in Texas Retevmo requires prior authorization from Cigna and is typically placed on a high specialty tier (4 or 5) with significant out-of-pocket costs. Your fastest path to approval: 1) Ensure you have genetic testing confirming RET fusion/mutation, 2) Have your

Work With Your Doctor to Get Retevmo (Selpercatinib) Approved by UnitedHealthcare in New York: Provider Partnership Guide

Answer Box: Getting Retevmo Covered by UnitedHealthcare in New York To get Retevmo (selpercatinib) approved by UnitedHealthcare in New York: Your oncologist must submit a prior authorization request with confirmed RET fusion testing results and clinical documentation. If denied, you have 180 days for internal appeals and 4 months for

The Requirements Checklist to Get Retevmo (selpercatinib) Covered by UnitedHealthcare in Pennsylvania

Answer Box: Fast Track to Approval To get Retevmo (selpercatinib) covered by UnitedHealthcare in Pennsylvania: 1) Confirm RET fusion-positive status with FDA-approved testing (FoundationOne CDx preferred), 2) Submit prior authorization through UnitedHealthcare provider portal with complete molecular pathology reports and clinical documentation, 3) If denied, file internal appeal within 6

Work With Your Doctor to Get Retevmo (selpercatinib) Covered by Humana in California: Templates, Timelines & Appeal Scripts

Quick Answer: Getting Retevmo (selpercatinib) Covered by Humana in California Humana Medicare Advantage requires prior authorization for Retevmo (selpercatinib) for RET fusion-positive cancers. Your oncologist must submit documentation proving RET alteration status through Evolent's portal or by calling 844-926-4528. If denied, you have 65 days to appeal and